Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

China · Delayed Price · Currency is CNY

17.22

-0.39 (-2.21%)

Sep 2, 2026, 3:00 PM CST

SHA:688639 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,005	2,862	2,178	1,938	1,419	954.1
Revenue Growth	13.36%	31.40%	12.37%	36.63%	48.69%	95.81%
Gross Profit	617.71	591.62	538.54	782.37	548.39	308.1
Operating Income	144.88	156.72	208.75	496.6	317.1	169.06
Net Income	118.38	132.41	189.52	449.06	320.03	168.24
Earnings Per Share	0.47	0.53	0.82	1.96	1.41	0.81
EPS Growth	-26.05%	-35.37%	-58.16%	39.31%	73.99%	13.35%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Overseas	1,128
China	1,183
Total	2,311

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	549.71	284.12	422.64	352.98	347.78	462.85
Total Debt	2,502	2,059	1,546	1,247	79.23	18.5
Net Cash (Debt)	-1,952	-1,775	-1,123	-893.67	268.55	444.35
Net Cash Growth	-	-	-	-	-39.56%	6128.38%
Net Cash Per Share	-7.78	-7.10	-4.86	-3.90	1.18	2.14

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	104.22	104.55	199.79	301.42	357.43	95.7
Capital Expenditures	-659.28	-636.73	-923.51	-1,269	-456.35	-180.63
Free Cash Flow	-555.06	-532.18	-723.72	-967.75	-98.92	-84.93
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	20.56%	20.67%	24.73%	40.36%	38.66%	32.29%
Operating Margin	4.82%	5.48%	9.59%	25.62%	22.35%	17.72%
Pretax Margin	3.33%	4.39%	9.25%	26.12%	24.18%	20.00%
Profit Margin	3.94%	4.63%	8.70%	23.17%	22.56%	17.63%
FCF Margin	-18.47%	-18.60%	-33.23%	-49.93%	-6.97%	-8.90%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.160	0.160	0.250	0.621	0.428	0.262
Dividend Per Share Growth	-36.00%	-36.00%	-59.72%	44.99%	63.33%	63.51%
Dividend Yield	0.92%	0.49%	0.79%	0.73%	0.60%	0.44%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	37.34	61.36	38.73	44.17	52.59	82.97
Forward PE	14.92	22.71	18.21	35.78	44.72	66.62
PS Ratio	1.46	2.84	3.37	10.23	11.86	14.63